This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Walgreens Unveils Success Of Medication Adherence Programs Through Improved Patient Adherence And Outcomes

Walgreens presented new research results at the Academy of Managed Care Pharmacy’s 24th Annual Meeting & Expo, April 18-20 in San Francisco, demonstrating the company’s success in driving better patient medication adherence through a diverse set of pharmacy programs. The studies illustrate how Walgreens approach to community pharmacy ultimately helps improve outcomes through cost savings, pharmacist-led face-to-face patient counseling and specialized services for disease management.

Three of the studies presented at the conference included:

  • Prescription Savings Club Membership Drives Medication Adherence: This study assessed the impact of enrollment in Walgreens Prescription Savings Club (PSC) on patient adherence to prescriptions used to treat diabetes. Comparison of medication adherence between PSC members and non-members revealed a nearly 10 percent higher medication possession rate for PSC members (77.9 percent vs. 68.0 percent). An increasing number of large employers are seeking methods to improve patient adherence. This study offers evidence that prescription discount memberships may improve medication adherence.
  • Impact of Community Pharmacist-Led Counseling on Patient Medication Adherence: This study demonstrated that pharmacist-led, face-to-face patient counseling significantly improves adherence to statin and thyroid medications in new-to-therapy patients. The pharmacist-led counseling resulted in an increase in one-year patient medication possession from 44 percent before the introduction of the program to 56 percent after the introduction of the program. Medication possession in a control group of patients of similar pharmacies without the program showed no significant increase in medication possession.
  • Impact of HIV-Specialized Pharmacies on Adherence to Antiretroviral Therapy (ART) Walgreens HIV Centers of Excellence (COE) pharmacies offer specialized services for HIV patients aimed at combatting barriers to adherence, which can lead to longer, healthier lives. At COE pharmacies, 62 percent of patients had adherence of 85 percent or more, compared with 57 percent of patients using community pharmacies.

Previous research also demonstrates that non-adherence with physician-prescribed medication treatment programs has a significantly negative impact on patient outcomes and overall health care costs. On average, 50 percent of patients do not take their medications as prescribed and 33 percent never even fill a new prescription 1. Eleven percent of hospital admissions and 40 percent of nursing home admissions are attributable to medication non-adherence, which has been estimated to cost the U.S. health care system $290 billion annually, including $100 billion in avoidable hospitalizations alone. 2,3 As the number of Americans taking prescription drugs and the prevalence of chronic conditions grows, reducing non-adherence has increasingly become an important focus for health plan sponsors.

“At Walgreens, our number one priority is offering our patients innovative, accessible and personalized solutions to staying well. And providing a support system to facilitate consistent adherence with prescribed medications is a key component of this,” said Kermit Crawford, Walgreens president of pharmacy, health and wellness services and solutions. “This research highlights how three initiatives, -- our Prescription Savings Club program, our face-to-face pharmacist disease management counseling, and our specialty pharmacy offerings -- can all meaningfully help improve adherence. These types of offerings not only benefit our patients, but also the overall health care system by ultimately helping improve outcomes and potentially reduce costs.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs